Bluebird Bio gets gene therapy EMA marketing nod accepted October 2, 2020 -- The European Medicines Agency (EMA) accepted Bluebird Bio's marketing authorization application for its investigational elivaldogene autotemcel gene therapy drug to treat patients with cerebral adrenoleukodystrophy.
Bio-Techne opens GMP manufacturing facility September 30, 2020 -- Bio-Techne has opened a 61,000-sq-ft good manufacturing practice (GMP) manufacturing facility in St. Paul, MN. The space will be dedicated to large-scale production of Escherichia coli-derived recombinant proteins for cell and gene-modified therapy workflows.
Irvine Scientific to exclusively distribute stem cell tech September 29, 2020 -- Fujifilm Irvine Scientific said it has become the exclusive worldwide distributor of cellnest, a recombinant peptide attachment substrate that's designed to provide optimal adhesion and proliferation of stem cells for cell and gene therapy research.
Bioray Labs develops nonviral targeted CAR T therapy September 28, 2020 -- Bioray Laboratories posted interim results from clinical trials of its nonviral programmed cell death 1 specific targeted chimeric antigen receptor (CAR) T therapy for relapsed/refractory B-cell non-Hodgkin lymphoma.